Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.120
-0.020 (-1.75%)
At close: Mar 5, 2026, 4:00 PM EST
1.130
+0.010 (0.89%)
After-hours: Mar 5, 2026, 4:18 PM EST

Boundless Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2022
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21
2565---
Market Cap Growth
-44.34%----
Enterprise Value
-42.74-39.81000
Last Close Price
1.122.90---
PE Ratio
--0.75---
PB Ratio
0.230.43---
P/TBV Ratio
0.230.33---
P/FCF Ratio
--1.02---
P/OCF Ratio
--1.06---
EV/EBITDA Ratio
-0.55---
EV/EBIT Ratio
-0.54---
EV/FCF Ratio
-0.63---
Debt / Equity Ratio
0.420.3200.040
Debt / EBITDA Ratio
-0.75-0.66-0.04-0.11-0.01
Debt / FCF Ratio
-0.94-0.75-0.05-0.13-0.01
Net Debt / Equity Ratio
-0.62-0.690.930.751.90
Net Debt / EBITDA Ratio
1.021.452.201.352.95
Net Debt / FCF Ratio
1.291.652.501.512.87
Quick Ratio
9.9318.7012.908.6318.89
Current Ratio
10.1418.9813.278.8019.28
Return on Equity (ROE)
-47.36%-48.21%-52.93%-52.16%-22.97%
Return on Assets (ROA)
-36.16%-43.57%-53.01%-48.77%-22.25%
Return on Invested Capital (ROIC)
-153.25%-304.40%-1613.31%-220.14%-67.65%
Return on Capital Employed (ROCE)
-38.20%-45.96%-57.79%-51.93%-23.03%
Earnings Yield
-246.35%-132.76%---
FCF Yield
-210.23%-98.00%---
Buyback Yield / Dilution
-0.84%-144.07%---
Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q